# Correlation between blood pressure variability and prognosis of endovascular therapy in ischemic stroke due to middle cerebral artery occlusion

**Authors:** Hao Tao, Yi Li, Huan Liu, Xiang Fan, Meng-Yu Zhong, Jian-Hong Wang, Shu Yang, Neng-Wei Yu, Bing-Hu Li

PMC · DOI: 10.3389/fneur.2026.1723520 · Frontiers in Neurology · 2026-02-20

## TL;DR

This study found that higher blood pressure variability after stroke treatment is linked to worse outcomes, but the results may not be reliable due to the small sample size.

## Contribution

The study identifies blood pressure variability as a potential predictor of poor outcomes after endovascular therapy for stroke.

## Key findings

- Higher systolic and pulse pressure variability were associated with poor 90-day outcomes after stroke treatment.
- Multivariable analysis showed systolic and pulse pressure variability independently predicted poor prognosis.
- The study suggests blood pressure variability may reflect stroke severity rather than being a causal factor.

## Abstract

To evaluate the impact of post-endovascular therapy (EVT) systolic, diastolic, and pulse pressure (PP) variability on 3 month functional outcomes in patients with middle cerebral artery occlusion.

Patients were classified as having good (mRS 0–2) or poor (mRS 3–6) 90 day outcomes. We compared 48 h postoperative BP parameters and BPV indices (SD, CV, and ARV). Multivariable logistic regression adjusted for age, baseline NIHSS, hypertension, atrial fibrillation, and pre-stroke mRS was used to examine associations between BPV and outcome.

The average real variability of systolic blood pressure (SBPARV: 10.08 vs. 7.89, p < 0.001), diastolic blood pressure (DBPARV: 8.42 vs. 7.87, p = 0.006), and PP (PPARV: 11.00 vs. 8.26, p < 0.001) were significantly higher in the poor prognosis group than in the good prognosis group. Multivariable logistic regression showed that SBPARV (OR = 2.619, 95% CI 1.606–4.271; p < 0.001) and PPARV (PPARV: 11.00 vs. 8.26, p < 0.001) were independently associated with poor prognosis at 3 months.

In this retrospective cohort, higher postoperative SBP ARV and PP ARV were independently associated with poor 90 day functional outcome after EVT; however, given the small sample size and observational design, the predictive value of BPV parameters is likely limited. BPV may be an epiphenomenon of more severe stroke rather than a causal determinant or clinically actionable target.

## Linked entities

- **Diseases:** ischemic stroke (MONDO:1060198)

## Full-text entities

- **Diseases:** Stroke (MESH:D020521), decline in neurological function (MESH:D003291), hemorrhage (MESH:D006470), respiratory failure (MESH:D012131), intracranial hemorrhage (MESH:D020300), comminuted limb, trunk, or spinal cord injuries (MESH:D013119), AIS (MESH:D000083242), critically ill (MESH:D016638), trauma (MESH:D014947), -HL (MESH:C538324), vascular sclerosis (MESH:D014652), ischemic (MESH:D002545), diabetes mellitus (MESH:D003920), LVO (MESH:C536223), malignant (MESH:D009369), cardiac insufficiency (MESH:D000309), renal failure (MESH:D051437), York Heart Association (MESH:D006331), hepatic failure (MESH:D017093), IV (MESH:D006011), organ damage (MESH:D000092124), infarct (MESH:D007238), neurological deterioration (MESH:D009422), LVO of MCA (MESH:D020244), C (OMIM:211750), hypertension (MESH:D006973), PP (MESH:D003668), skull fractures (MESH:D012887), Child-Pugh (MESH:C562515), atrial fibrillation (MESH:D001281), cerebral infarction (MESH:D002544), artery remodeling (MESH:D066253), EVT (MESH:D016609), CKD (MESH:D012080), cardiovascular disease (MESH:D002318)
- **Chemicals:** aspirin (MESH:D001241), blood glucose (MESH:D001786), cholesterol (MESH:D002784), TC (MESH:D013667), oxygen (MESH:D010100), Triglycerides (MESH:D014280), rivaroxaban (MESH:D000069552), warfarin (MESH:D014859), TG (MESH:D013866), clopidogrel (MESH:D000077144), BPV (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12962930/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12962930/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12962930/full.md

---
Source: https://tomesphere.com/paper/PMC12962930